Skandinaviska Enskilda Banken (SEB)’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
Skandinaviska Enskilda Banken (SEB)'s NEO Position: Q1 2024 in Review
Skandinaviska Enskilda Banken (SEB) sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 41,500 shares — an estimated $671K sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in NEO in Q2 2020 and held it in 11 quarters. The position peaked at $1.69M in Q3 2021. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.
- Skandinaviska Enskilda Banken (SEB) reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 41,500 NeoGenomics shares in Q1 2024, an estimated $671K.
- Skandinaviska Enskilda Banken (SEB) first reported a position in NeoGenomics in Q2 2020 and held it in 11 quarters.
- Skandinaviska Enskilda Banken (SEB)'s NeoGenomics position peaked at $1.69M in Q3 2021.
- 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.